Ecolab Inc.
ECL · NYSE
ECL · NYSE
Ecolab sells water-treatment, hygiene, cleaning, infection-prevention and pest-management products and services. Its customers span industrial companies, institutions, healthcare providers, hospitality and foodservice operators, and commercial and residential locations. The business is organized around Global Industrial, Global Institutional, Global Healthcare and Life Sciences, and Global Pest Elimination activities, earning revenue from chemical products, equipment, monitoring and ongoing service relationships. The supplied evidence does not disclose the revenue contribution of each segment. Ecolab reported $16.1 billion of FY2025 revenue and $2.1 billion of net income, compared with $15.7 billion and $2.1 billion, respectively, in FY2024.
Ecolab shares gained $0.24, or 0.08%, from $282.90 to $283.14 over the measured period. Trading was volatile beneath the flat net result: the stock rose to $283.70 on July 29, then fell to $279.34 and $277.63 over the next two sessions before rebounding to $279.43 on August 3 and $283.14 on August 4. The supplied evidence does not identify company-specific news during the week. The main market-related signal was an approximately $105.9 million outflow from the Materials Select Sector SPDR ETF, which included Ecolab and may have weighed on materials holdings. Prior commentary cited strong second-quarter 2026 results and a raised profit forecast, but no timing was supplied.
Ecolab | ECL Stock Price, Company Overview & News
